Cancer endometrial nccn, Uterine cancer nccn 2019

Nccn prostate cancer guidelines pdf

Nicolae Ghilezan, with 28 radiotherapists as founding members.

nccn prostate cancer guidelines pdf

It is a dedicated professional society for radiotherapy but open to individuals in all oncology specialties surgeons, biologists, medical oncologists, pathologists, physicists, radiotherapy technologist, etc. In the General Assembly of the society decided to change the name to the Romanian Society for Radiotherapy and Medical Oncology RSRMO due to the increasing number of medical oncologist members and increased financial support from this branch of the profession.

Main Objectives The purpose of RSRMO is to bring together specialists in the field of medical oncology and radiotherapy in order to contribute to the increase in quality of oncological care.

NCCN Guidelines (V.1.2020)

RSRMO aims to establish a high professional standard through supporting specialist education at all levels university, post-graduate, doctoral for all its members physicians, physicists, biologists, etc. An important objective of the society is to protect the interest of its members and of oncology and radiotherapy in general in dealings with the organizations overlooking their activities the Ministry of Health, the Government, the Ministry of Education, county health departments.

The society promotes equal and unrestricted access for all patients to optimal cancer treatment.

RSRMO aims to promote the collaboration of specialists in the field of oncology and radiotherapy, as well as the collaboration with specialists in other oncology-related fields. It promotes collaboration with international organizations of medical oncology and radiotherapy, cancer foundations, universities, patient groups and the representatives of the pharmaceutical and medical technology industries.

nccn prostate cancer guidelines pdf

The society proposes to inform and educate patients, the civil society and the general public about the issues related to the prevention, diagnosis and treatment of all malignant disorders. The Executive Board of the Society is elected by the General Assembly for a term of three years and it consists of five members: the Secretary, three Presidents the Executive President and two Vice Presidents and nccn prostate cancer guidelines pdf treasurer.

Each President heads the Executive Board for one year.

  • B Argumentare Chirurgia în aceste cazuri creşte supravieţuirea cu aproximativ 2 ani.
  • Endometrial cancer treatment guidelines, - Cancer endometrial nccn
  • Prostata tabletten pflanzlich
  • Prostata la barbati cauze
  • Rectal cancer nccn guidelines - Cancer de prostată și boli de prostată (Martie )
  • Magnetic Resonance Imaging MRI is the best imaging modality for evaluating the prostate and accurately diagnose the prostatic carcinoma, especially in cases with aggressive and larger volume tumors.

The Executive Board conducts its activities with the help of a durerea de rinichi simptome of committees appointed by it: the committee for organizing the National Congress, the scientific committee, the education committee, the ethics committee, the elections committee, etc.

The General Assembly consists of all the members of the Society and meets at least once a year at the National Congress. Every year RSRMO organizes a congress for specialists in radiotherapy and medical oncology with the participation of its members as well as other specialists involved in RSRMO activities and specialists of oncology-related fields surgeons, physicists, radiobiologists, pathologists, etc.

nccn prostate cancer guidelines pdf

RSRMO organizes Annual Congresses focusing on contemporary topics, building relationships amongst the different specialists involved in cancer care and research. The opening session of each year s congress is called The Resident s Afternoon and it is aimed at residents. This is the forum where residents of radiotherapy, medical oncology and other specialties present the results of their research, with prizes going to the three most significant presentations.

The first issue was published in in Romanian and since it is being published in English, with four issues annually. Our Journal publishes papers which are of nccn prostate cancer guidelines pdf high standard and which contribute to the advancement of knowledge in the field of radiotherapy and medical oncology.


The journal also publishes review articles, case reports and brief communications including book reviews on those specific topics. RSRMO offers fellowships and grants travel, registration fees for international courses and congresses for residents in radiotherapy or medical oncology, as well as of radiotherapy physicists.

nccn prostate cancer guidelines pdf

RSRMO is involved in clinical practice through regular evaluations of the radiotherapy practice in Romania and analysis of clinical results in all cancer centers e. The evaluation reports have been published in the Journal of the Society. RSRMO has an important role in supporting scientific research, reflected in publications in international journals. Journal of Clinical Oncology, 28,; Tudor Ciuleanu et al.

Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis TITAN : a randomised multi-centre, open-label, phase 3 study.

Cancer endometrial nccn

Lancet Oncol. The multidisciplinary treatment of advanced cervical cancer has been the focus of a number of randomised, singleinstitution trials which initially evaluated the effectiveness of exclusive radiotherapy vs.

Quality of life and treatment related toxicity in patients with locally advanced cervical carcinoma treated by two chemoradiation regimens.

nccn prostate cancer guidelines pdf

Strahlenther Onkol, 3, 85, ; Nagy, Viorica Magdalena, et al. International Journal of Gynaecological Cancer, 22, 9, Of the various other national societies with whom we have been in collaboration we must mention a number who have supported our society through continuous medical education programs that many of our members benefited from, as well as through conferences and courses given at various RSRMO events. We also need to mention the course organized by our society in collaboration with the University of Medicine and Pharmacy Iuliu Hatieganu Cluj-Napoca in which also had international lecturers: renowned radiotherapists and medical physicists from William Beaumont Hospital, Royal Oak, USA and the Brachytherapy course organized in collaboration with a team from the Radiotherapy Department of the Vienna General Hospital AKH.

However, there are still a number of unsolved problems in radiotherapy in Romania, primarily due to the great deficiency in radiotherapy equipment which makes it difficult for patients to access radiotherapy treatment.

Other problems include the deficiency in reimbursement of cancer treatment, the inconclusive dialogue with central authorities, etc. RSRMO has made repeated appeals to the Ministry of Health pointing out the problems and proposing solutions for the improvement of the situation of radiotherapy in Romania.

The society has established a Resident Group for radiotherapy and medical oncology residents which has 83 members. This group aims to establish a high professional standard for residents, to protect the interest of residents, to collaborate with residents in other fields, to collaborate and develop common projects with international societies of residents of radiotherapy and medical oncology, with cancer organizations and foundations, universities, patient groups, etc.

  • Rectal cancer nccn guideline - festivalulaltfel.
  • Tratamentul prostatitei tehnică nouă
  • Indicele simptomelor prostatitei
  • Cancer endometrial nccn.

Even though RSRMO is a small national society, in its existence it has had a very fruitful activity, seeking to fulfill the main objectives of its statute. We propose to maintain the high standard we have established and to increase the society s activity both nationally and internationally. Ciuleanu Immune oncology versus targeted therapies in solid tumors is there a winner?

Curca De ente et essentia. Understanding cancer genomics in the selection of the best targeted therapy. Resist the resistance. Ciuleanu Precision medicine insights in breast cancer A. Jinga Closing remarks and take home messages T. Chis Characteristics of brachytherapy sources used for the treatment of prostate cancer Edina Dordai Treatment planning using Volumetric Modulated Arc Therapy for esophageal tumors R.

Bucur Left sided breast cancer radiation therapy.

Rectal cancer nccn guidelines. [Antibiotic prophylaxis in surgery for colorectal cancer].

Mihaila Volumetric modulated Arc therapy in the treatment of rectal adenocarcinoma: initial experience Elena Manea Solid pseudopapillary tumor of the pancreas: clinicopathologic features and management of 3 cases O. Bochis Treatment with folfirinox in locally advanced and metastatic pancreatic cancer R. Vidra Chemoresponsivness to neoadjuvant chemotherapy novel prognostic factor for patients with locally advanced cervcal carcinoma Domnica Carpov Efficacy and toxicity of treatment with cetuximab in metastatic colorectal cancer: the experience of the Oncology Institute Cluj-Napoca Adina Nemes The role of sequentiality in the multidisciplinary treatment of cervical cancer Claudia-Diana Sabau Three-dimensional conformal radiotherapy in cervical cancer, stage IIB-IIIB: experience of the Oncology Institute Prof.

Tanasescu, R. Mirabel Medical physicists Meeting A. Vancea Time trends of incidence and mortality by lung cancer Ofelia Suteu Initiatives for improving diagnosis of lung cancer -what is different for Romania? Vancea Software-assisted quality improvement in thoracic X-RAY imaging aiding cancer nccn prostate cancer guidelines pdf Iolanda Dumitrescu Early detection of lung cancer and diagnosis of genetic predisposition Z.

Ciuleanu, A. Ciuleanu, M. Dediu New molecules under development in lung cancer at Gustave Roussy J. Costache State of art in the intensity modulated radiotherapy of the lung cancer I. Chiricuta Is concomitant chemoradiation an undisputable gold standard for locoregionally advanced disease? Renata Zahu Principles of medical treatment for neuroendocrine tumors Rodica Anghel Brachytherapy for lung cancer: utopia or reality in Romania?

nccn prostate cancer guidelines pdf

Kacso, C. Miron, C. Cainap Smallcell lung cancer-promises and pitfalls in L. Savu, A. Moga Different modalities of irradiation in superior vena cava compression syndrome historical perspective M. Adeberg Pulmonary adverse events in combined treatment of locally-advanced non-small cell lung cancer la NSCLC Petronela Rusu Incidence, severity and management of skin toxicity associated with EFGR inhibitors therapy in head and neck and lung cancer patients Rodica Anghel State of art in the intensity modulated radiotherapy of the esophageal cancer I.

Chiricuta Esophageal cancer. A retrospective study from the Institute of Oncology Prof. Popa Iasi 4.

NCCN Guidelines for Patients Hodgkin Lymphoma 2019

Cainap 5. Carol Davila, Bucuresti 6. India 9. Pop 2. Oncologycal Institute I. Chiricuta Cluj-Napoca, 2 2. UMF Cluj-Napoca, 3 3.